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An environmental friendly, economical and clean Biginelli approach in presence of readily available zinc acetate dihydrate 
(Zn(OAc)2.2H2O) to access biologically active 3,4-dihydropyrimidin-2-(1H)-ones/thiones derivatives via one-pot, three-component 
reaction of β-keto esters (methyl or ethyl acetoacetate), aromatic aldehyde (benzaldehye derivatives) and urea or thiourea in high to 
excellent yields has been studied. This solvent-free procedure is sustainable and advantageous compared to conventional methods due to 
short reaction times, one-pot procedure, easy handling, efficient, environmentally benign nature, low-cost and non-toxic catalyst, eco-
friendly, ready availability of starting materials and no requirement of chromatographic purification. The products have been 
characterized by melting points and 1H NMR spectroscopy. 
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In recent years, the design and development of 
bioactive heterocyclic compounds synthesis performed 
through multi-component reactions (MCRs)1-6, 
involving three or more reactants in one-pot, have 
attracted considerable interest since such processes 
improve atom economy, efficiency and convergence. 
Pyrimidinone derivatives are a common structural 
motif in variety of natural and non-natural products. 
Their derivatives have been known to exhibit a wide 
range of pharmacological and biological properties 
(Figure 1). For example these heterocyclic 
compounds have been used as calcium channel 
blockers, α-1a-antagonists7, mitotic kinesin Eg5 
inhibition8, anti cancer (Mal3-101)9, anti HIV agent10, 
antibacterial and antifungal11, antiviral12, 
antioxidative13. The representatives such as 
batzelladines, ptilomycalines and crambescidines 
exhibit many biological activities such as anticancer, 
antifungal, anti HIV, etc.14 
Typically, processes involved in the synthesis of 
these compounds are catalyzed by different 
catalysts15-26. Some of the limitations of these 
methodologies are low yields, toxic organic solvents 
and catalyst, harsh reaction conditions and expensive 
materials. 
Based on the above considerations and our interest 
in the design of efficient and environmental benign 
methodologies, attempts were directed to synthesize 
one of Biginelli-type reactions27. Finally, herein, we 
report a simple, clean and mild procedure  
for synthesis of 3,4-dihydropyrimidin-2-(1H)-
ones/thiones derivatives via reaction of β-keto esters, 
aldehyde derivatives and urea/thiourea by using of 
Zn(OAc)2.2H2O as a catalyst under thermal and 
solvent-free conditions with excellent yields and short 
reaction times (Scheme I). During the past decades, 
the use of zinc compounds as environmental safe 
catalysts in organic synthesis have attracted great 
interest due to their notable advantages such as non-
toxic, environmentally-friendly, easy to handle, 
highly efficient and low-cost28,29. Also 
Zn(OAc)2.2H2O can be successfully used in the type 
of carbon-carbon bonds as an available, eco-friendly 
and environmental friendly catalyst30-32 in organic 
synthesis. Short reaction times, high to excellent 
yields, eco-friendly, one-pot and efficient, readily, 
low-cost and non- toxic catalyst that makes our 
protocol alternative in comparison to some of the 
earlier reported methods. 
Furthermore, one of the source of environmental 
pollutions is the usage of organic solvents under 
reflux conditions and the need for column 
chromatography to purity the products. In this present 
work, the products were obtained through simple 




filtering with no need column chromatographic 
separation. 
 
Results and Discussion 
At beginning we performed three-component 
condensation Biginelli reaction of benzaldehyde (1, 
1.0 mmol), urea (3, 1.5 mmol) and ethyl acetoacetate 
(2, 1.0 mmol) in the present of Zn(OAc)2.2H2O (15 
mol%) under solvent-free at 70 °C, the product 4a was 
found in 89%, which was confirmed by 1H NMR 
spectroscopy. Encouraged by this result, we chosen 
this reaction as a model reaction to study the reaction 
conditions further for the synthesis of 3,4-
dihydropyrimidin-2-(1H)-ones/thiones derivatives 
(4a-s). The catalyst plays an important role in the 
success of the reaction in terms of rate of the reaction 
and yields. In order to optimize the reaction 
conditions, quantity of the catalyst required was 
determined. No product could be detected in the 
absence of the catalyst even after 4h (Table I, entry 
1). Then, 5 mol% Zn(OAc)2.2H2O was used to 
perform the reaction. But it requires slightly long 
reaction time and low yields. Therefore, the loading 
of catalyst was gradually increased from 5 mol% to 
20 mol% (Table I). It was found that 15 mol% of 
Zn(OAc)2.2H2O is optimal to carry out the reactions 
in a short duration (Table I, entry 4). The use of 
excess of catalyst did not alter either reaction time or 
yield of the product. Thus, the use of 15 mol% 
Zn(OAc)2.2H2O is ideal to achieve the desired 
product in high yields. We also investigated different 
temperatures for the model reaction Table I). It was 
observed that fast reaction occurred on raising the 
temperature from RT to 80 °C and the yield of 
preferred product increased significantly (Table I). 
We were satisfied to find that the reaction proceeded 
smoothly and almost complete conversion of reactants 
was observed at 70 °C to afford the desired product 
(4a) in 89% yields within 15 min (Table I, entry 4). 




























Figure 1 — Biologically active compounds containing the dihydropyrimidine unit 
 
(X)  2a= O; 2b= S







+ Zn(OAc)2.2H2O (15mol %)











(Ar)1a,1b=Ph; 1c= 3-Cl-C6H4; 1d, 1e= 4-Cl-C6H4; 1f= 4-OH-C6H4; 1g= 4-Me-C6H4; 1h= N,N-di Me-C6H3; 1i, 1j= 3-
MeO- C6H4; 1k= 4-MeO-C6H4; 1l= 4-NO2-C6H4; 1m= 4-F-C6H4; 1n, 1o=2-Cl-C6H4; 1p= 4-MeO-C6H4; 1q= 4-F-C6H4; 
1r= 4-NO2-C6H4; 1s= 4-OH-C6H4
 
 
Scheme I — Synthesis of 3,4-dihydropyrimidin-2-(1H)-one/thione derivatives 
 




product yield (Table I, entry 8). Having optimized 
reaction conditions for the synthesis of 3,4-
dihydropyrimidin-2-(1H)-ones/tiones derivatives (4a-
s) using 15 mol% Zn(OAc)2.2H2O as the  
catalyst under solvent-free conditions at 70 °C  
we subsequently applied for a variety of  
aldehydes, urea/ thiourea and ethyl/methyl 
acetoacetate (Table II). 
Proposed mechanistic route of 3,4-
dihydropyrimidin-2-(1H)-ones/thiones synthesis in 
the presence of zinc acetate dihydrate are shown in 
Scheme II. In this probable mechanism, the zinc 
acetate dihydrate catalyzed Biginelli condensation via 
acylimin intermediate (A) is presented in Scheme II. 
The reaction of aldehydes (1) and urea(2) generates 
an acylimin intermediate (A), which further reacts 
with the activated 1,3-dicarbonyl compound (B) 
producing an open-chain ureide (C) undergoing 
subsequent cyclization and dehydration to give the 
major product (4). 
 
 















Isolated Yields (%) Time (min) Temperature (°C) Zn(OAc)2.2H2O (mol %)
 Entry 
Not product 240 70 Catalyst free 1 
53 35 70 5 2 
71 20 70 10 3 
89 15 70 15 4 
Not product 360 rt 15 5 
49 45 40 15 6 
74 25 60 15 7 
89 15 80 15 8 
90 15 70 20 9 
a Reaction conditions: benzaldehyde (1.0 mmol), ethyl acetoacetate (1.0 mmol), urea (1.5mmol) and zinc acetate dihydrate was heated 
under various temperatures for the appropriate time. 
 
Table II — Synthesis of 3,4-dihydropyrimidin-2-(1H)-ones/thiones derivatives 


























































Scheme II — Proposed mechanistic route for the synthesis of 3,4-dihydropyrimidin-2-(1H)-ones/thiones 
 




Table II — Synthesis of 3,4-dihydropyrimidin-2-(1H)-ones/thiones derivatives (Contd.) 















































































































































Table II — Synthesis of 3,4-dihydropyrimidin-2-(1H)-ones/thiones derivatives (Contd.) 

















































































































































Table II — Synthesis of 3,4-dihydropyrimidin-2-(1H)-ones/thiones derivatives (Contd.) 








































































































































a Isolated yield. 
b Reaction conditions: benzaldehyde (1.0 mmol), ethyl/methyl acetoacetate (1.0 mmol), urea/thiourea (1.5 mmol) and zinc acetate 
dihydrate (15 mol %) was heated at 70 °C. 
 
 




Comparison of catalytic ability some of catalysts 
reported in the literature for synthesis of 3,4-
dihydropyrimidin-2-(1H)-ones/thiones derivatives are 
shown in Table III. Also 1H NMR data of products 
have been compared with literature (Table IV). This 
study reveals that zinc acetate dihydrate 
(Zn(OAc)2.2H2O) has shown its extraordinary 
potential to be an alternative readily, environmental 
friendly, efficient, low-cost and economical catalyst 
for the Biginelli reaction. In addition, the use of 
solvent-free conditions with excellent yields and short 
reaction times in the reaction with both urea and 





Melting points of all compounds were determined 
using an Electro Thermal 9100 apparatus. 1H NMR 
spectra were recorded on a Bruker DRX-400 Avance 
instrument with DMSO-d6 as solvent. All reagents 
and solvents were purchased from Merck, Fluka and 
Acros chemical companies and used without further 
purification. 
 
General procedure for preparation of 3,4-
dihydropyrimidin-2-(1H)-ones/thiones derivatives, 
4a-s 
A mixture of aldehydes derivatives (1, 1.0 mmol) 
and urea/thiourea (3, 1.5 mmol), ethyl/methyl 
acetoacetate (2, 1.0 mmol) was heated under solvent-
free conditions at 70°C for appropriate time in the 
presence of Zn(OAc)2.2H2O (15 mol %). After 
completion of the reaction ( determined by thin layer 
chromatography TLC) the mixture was cooled to RT, 
cold water added, the precipitate separated with 
filtration and recrystallized from ethanol to afford the 




dihydropyrimidin-2(1H)-one, 4a: Crystalline solid. 
Yield 89%. m.p.202-204°C. 1H NMR (400 MHz, 
DMSO-d6): δ 1.10 ( 3H, t, J= 7.2 Hz, CH3CH2), 2.26 
(3H, s, CH3), 3.99 (2H, q, J=7.2 Hz, CH2O), 5.15 ( 
1H, s, CHN), 7.26 ( 3H, d, J= 7.2 Hz, ArH), 7.33 (2H, 
t, J=7.2 Hz, ArH), 7.76 and 9.21 (2H, 2s, 2NH). 
5-Ethoxycarbonyl-6-methyl-4-phenyl-3,4-
dihydropyrimidin-2(1H)-thione, 4b: Crystalline 
solid. Yield 86%. m.p.207-209°C. 1H NMR (400 
MHz, DMSO-d6): δ 1.11 (3H, t, J= 7.2 Hz, CH3CH2), 
2.31 (3H, s, CH3), 4.02 (2H, q, J=7.2 Hz, CH2O), 5.19 
(1H, s, CHN), 7.23 (2H, d, J=7.2 Hz, ArH), 7.28 (1H, 
t, J=7.2 Hz, ArH), 7.36 (2H, t, J=7.2 Hz, ArH), 9.68 
and 10.36 ( 2H, 2s, 2NH). 
5-Ethoxycarbonyl-6-methyl-4-(4-hydroxyphenyl) 
-3,4-dihydropyrimidin-2(1H)-one, 4f: Crystalline 
solid. Yield 76%. m.p.233-236°C. 1H NMR (400 
MHz, DMSO-d6): δ 1.11 (3H, t, J= 9.6 Hz, CH3CH2), 
2.50 (3H, s, CH3), 3.98 (2H, q, J=9.2 Hz, CH2O), 5.04 
(1H, s, CHN), 6.68-7.04(4H, m, ArH), 7.64 and 9.13 
(2H, 2s, 2NH), 9.35 (1H, s, OH). 
5-Ethoxycarbonyl-6-methyl-4-(4-methoxyphenyl) 
-3,4-dihydropyrimidin-2(1H)-one, 4k: Crystalline 
solid. Yield 82%. m.p.201-203°C. 1H NMR (400 
MHz, DMSO-d6): δ 1.11 (3H, t, J= 9.6 Hz, CH3CH2), 
2.24(3H, s, CH3), 3.73 (3H, s, OCH3), 3.99 (2H, q, 
J=9.6 Hz, CH2O), 5.09 (1H, s, CHN), 6.89 (2H, d, J= 
8.4Hz, ArH), 7.15 (2H, d, J= 8.8Hz, ArH), 7.70 and 
9.18 (2H, 2s, 2NH). 
5-Ethoxycarbonyl-6-methyl-4-(4-nitrophenyl)-
3,4-dihydropyrimidin-2(1H)-one, 4l: Crystalline 
solid. Yield 91%. m.p.206-208°C. 1H NMR (400 
MHz, DMSO-d6): δ 1.10 (3H, t, J= 9.6 Hz, CH3CH2), 
2.28(3H, s, CH3), 3.99 (2H, q, J=9.2 Hz, CH2O), 5.27 
(1H, s, CHN), 7.50-7.53 (2H, m, ArH), 7.23 (2H, d, 
J= 9.2Hz, ArH), 7.92 and 9.38 (2H, 2s, 2NH). 
 
Table III — Comparison of catalytic ability some of catalysts reported in the literature for synthesis of  
3,4-dihydropyrimidin-2-(1H)-ones/thiones derivatives a 
Ref. No. Time/Yield (%) Conditions Catalyst Entry 
17 24h/84 RT Bakers, yeast 1 
18 35 min/84 Solvent-free, 80 °C Hydrotalcite 2 
19 20 h/81 MeCN, Reflux [Al(H2O)6](BF4)3 3 
21 30 min/90 RT Cu(BF4)2.xH2O 4 
23 30 min/96 Solvent-free, 90 °C [Btto][p-TSA] 5 
24 45min/90 Solvent-free, 70 °C Triethylammonium acetate 6 
25 3 h/94 Solvent-free, 80 °C p-Dodecylbenzenesulfonic acid 7 
26 3 h/95 EtOH/Reflux TMSPTPOSA  8 
This work 15 min/89 Solvent-free, 70 °C Zn(OAc)2.2H2O 9 
a Based on the three-component reaction of benzaldehyde, ethyl acetoacetate and urea. 
 




Table IV — Comparison of 1H NMR data 
Entry  Product H Shift (Found) H Shift (Lit.) Ref. 
1 4a 1.10 ( 3H, t, J= 7.2 Hz, CH3CH2) 
2.26 (3H, s, CH3) 
3.99 (2H, q, J=7.2 Hz, CH2O) 
5.15 ( 1H, s, CHN) 
7.76 and 9.21 (2H, 2s, 2NH) 
1.15 ( 3H, t, J= 6.5 Hz, CH3CH2) 
2.30 (3H, s, CH3) 
4.00 (2H, q, J=6.5 Hz, CH2O) 
5.20 ( 1H, s, CHN) 
7.74 and 9.20 (2H, 2s, 2NH) 
 
21 
2 4b 1.11 (3H, t, J= 7.2 Hz, CH3CH2) 2.31 (3H, s, CH3) 
4.02 (2H, q, J=7.2 Hz, CH2O) 5.19 (1H, s, CHN) 
9.68 and 10.36 ( 2H, 2s, 2NH) 
 
1.09 (3H, t, J= 7.00 Hz, CH3CH2) 2.28  
(3H, s, CH3) 
4.00 (2H, q, J=7.00 Hz, CH2O) 5.16  
(1H, s, CHN) 
9.64 and 10.33 ( 2H, 2s, 2NH) 
 
21 
3 4f 1.11 (3H, t, J= 9.6 Hz, CH3CH2) 2.50 (3H, s, CH3) 
3.98 (2H, q, J=9.2 Hz, CH2O) 5.04 (1H, s, CHN) 
7.64 and 9.13(2H, 2s, 2NH) 
9.35 (1H, s, OH)  
1.08 (3H, t, J= 7.00 Hz, CH3CH2) 2.21  
(3H, s, CH3) 
3.96 (2H, q, J=7.00 Hz, CH2O) 5.02  
(1H, s, CHN) 
7.64 and 9.10(2H, 2s, 2NH) 
9.34 (1H, s, OH)  
 
21 
4 4k 1.11 (3H, t, J= 9.6 Hz, CH3CH2) 2.24(3H, s, CH3) 
3.73 (3H, s, OCH3) 
3.99 (2H, q, J=9.6 Hz, CH2O) 5.09 (1H, s, CHN) 
7.70 and 9.18 (2H, 2s, 2NH)  
1.00 (3H, t, J= 6.78 Hz, CH3CH2) 2.20 
(3H, s, CH3) 
3.70 (3H, s, OCH3) 
3.96 (2H, q, J=6.80 Hz, CH2O) 5.07  
(1H, s, CHN) 
7.64 and 9.14 (2H, 2s, 2NH)  
 
21 
5 4l 1.10 (3H, t, J= 9.6 Hz, CH3CH2) 2.28(3H, s, CH3) 
3.99 (2H, q, J=9.2 Hz, CH2O) 
5.27 (1H, s, CHN) 
7.92and 9.38 (2H, 2s, 2NH) 
 
1.08 (3H, t, J= 7.00 Hz, CH3CH2) 2.25 
(3H, s, CH3) 
3.97 (2H, q, J=7.00 Hz, CH2O) 
5.26 (1H, s, CHN) 
7.89and 9.35 (2H, 2s, 2NH) 
 
21 
6 4n 1.00 (3H, t, J= 9.2 Hz, CH3CH2) 2.31 (3H, s, CH3) 
4.02 (2H, q, J=9.2 Hz, CH2O)  
5.63 (1H, s, CHN) 
7.73 and 9.29(2H, 2s, 2NH) 
0.97 (3H, t, J= 6.9 Hz, CH3CH2) 2.28  
(3H, s, CH3) 
3.87 (2H, q, J=6.9 Hz, CH2O)  
5.61 (1H, s, CHN) 
7.70 and 9.25(2H, 2s, 2NH) 
 
21 
7 4o 2.31 (3H, s, CH3) 
3.46 (3H, s, OCH3) 
5.62 (1H, s, CHN) 
7.72 and 9.36(2H, 2s, 2NH) 
2.33 (3H, s, CH3) 
3.48 (3H, s, OCH3) 
5.64 (1H, s, CHN) 
7.70 and 9.32(2H, 2s, 2NH) 
 
21 
8 4r 2.28(3H, s, CH3) 
3.55 (3H, s, OCH3) 
5.28 (1H, s, CHN) 
7.93 and 9.40 (2H, 2s, 2NH) 
2.25(3H, s, CH3) 
3.52 (3H, s, OCH3) 
5.26 (1H, s, CHN) 




3,4-dihydropyrimidin-2(1H)-one, 4n: Crystalline 
solid. Yield 85%. m.p.221-223°C. 1H NMR (400 
MHz, DMSO-d6): δ 1.00 (3H, t, J= 9.2 Hz, CH3CH2), 
2.31 (3H, s, CH3), 4.02 (2H, q, J=9.2 Hz, CH2O), 5.63 
(1H, s, CHN), 7.25-7.34 (3H, m, ArH), 7.41 (1H, d, 
J=8.8 Hz, ArH), 7.73 and 9.29 (2H, 2s, 2NH). 
5-Methoxycarbonyl-6-methyl-4-(2-chlorophenyl) 
-3,4-dihydropyrimidin-2(1H)-one, 4o: Crystalline 
solid. Yield 83%. m.p.250-252°C. 1H NMR (400 
MHz, DMSO-d6): δ 2.31 (3H, s, CH3), 3.46 (3H, s, 
OCH3), 5.62 (1H, s, CHN), 7.28-7.34 (3H, m, ArH), 
7.42 (1H, d, J=7.2 Hz, ArH), 7.72 and 9.36 (2H, 2s, 
2NH). 
5-Methoxycarbonyl-6-methyl-4-(4-nitrophenyl)-
3,4-dihydropyrimidin-2(1H)-one, 4r: Crystalline 
solid. Yield 92%. m.p.215-217°C. 1H NMR (400 
MHz, DMSO-d6): δ 2.28(3H, s, CH3), 3.55 (3H, s, 




OCH3), 5.28 (1H, s, CHN), 7.52 (2H, d, J= 8.4Hz, 
ArH), 7.22 (2H, d, J= 8.8Hz, ArH), 7.93 and 9.40 
(2H, 2s, 2NH). 
 
Conclusion 
In summary, a facile and clean procedure for 
Biginelli synthesis of biologically active 3,4-
dihydropyrimidin-2-(1H)-ones/thiones derivatives via 
one-pot three-component reaction of aldehydes, 
urea/thiourea and ethyl/methyl acetoacetate in the 
present of an efficient and readily zinc acetate 
dihydrate (Zn(OAc)2.2H2O) as catalyst under thermal 
and solvent-free conditions have described. The 
notable advantages of the synthetic routes are 
including efficient, eco-friendly, readily, inexpensive 
and non-toxic catalyst, solvent-free conditions, high 
to excellent yields, one-pot procedure and 
environmentally benign nature synthesis.  
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